Osagrand 150 mg Tabletki powlekane Polska - polski - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

osagrand 150 mg tabletki powlekane

zentiva, k.s. - natrii ibandronas monohydricum - tabletki powlekane - 150 mg

Osagrand 3 mg Roztwór do wstrzykiwań Polska - polski - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

osagrand 3 mg roztwór do wstrzykiwań

zentiva, k.s. - natrii ibandronas monohydricum - roztwór do wstrzykiwań - 3 mg

Spikevax (previously COVID-19 Vaccine Moderna) Unia Europejska - polski - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - szczepionki - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Comirnaty Unia Europejska - polski - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - szczepionki - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. stosowanie tej szczepionki powinno odbywać się zgodnie z oficjalnymi zaleceniami.

Oktaseptal (0,10 g + 2,00 g)/100 g Roztwór na skórę Polska - polski - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

oktaseptal (0,10 g + 2,00 g)/100 g roztwór na skórę

zakłady farmaceutyczne "unia" spółdzielnia pracy - octenidini dihydrochloridum + phenoxyethanolum - roztwór na skórę - (0,10 g + 2,00 g)/100 g

Mel Max Actigel 20 mg/g Żel Polska - polski - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

mel max actigel 20 mg/g Żel

przedsiębiorstwo produkcji farmaceutycznej hasco-lek s.a. - diclofenacum natricum - Żel - 20 mg/g

Adarostin 10 mg/g Żel Polska - polski - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

adarostin 10 mg/g Żel

medicofarma s.a. - diclofenacum natricum - Żel - 10 mg/g

Undofen Amorolfina 50 mg/ml Lakier do paznokci leczniczy Polska - polski - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

undofen amorolfina 50 mg/ml lakier do paznokci leczniczy

perrigo poland sp. z o.o. - amorolfinum - lakier do paznokci leczniczy - 50 mg/ml

Neocolipor Unia Europejska - polski - EMA (European Medicines Agency)

neocolipor

boehringer ingelheim vetmedica gmbh - e. coli adhesin f4 (f4ab, f4ac, f4ad), e. coli adhesin f5, e. coli adhesin f6, e. coli adhesin f41 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - sows; sows (nullipar) - ograniczenie enterotoksykozy noworodków prosiąt wywołane przez e. szczepy coli, wyrażające adhezyny f4ab, f4ac, f4ad, f5, f6 i f41, podczas pierwszych dni życia.

Nityr Unia Europejska - polski - EMA (European Medicines Agency)

nityr

cycle pharmaceuticals (europe) ltd - nitisinon - tyrosinemias - inne przewodu pokarmowego i przemianę materii narzędzia, - leczenie i pediatrycznych pacjentów dorosłych z potwierdzonym rozpoznaniem dziedzicznego тирозинемии 1 (xt-1) w połączeniu z dietetycznych ograniczeniem tyrozyny i fenyloalaniny.